DOCSLIB.ORG

The Search for a Treatment for Ageing

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Search for a Treatment for Ageing The search for a treatment for ageing OVERVIEW • Geroscience research is exploring and some are already being tested in human interventions that delay biological ageing and clinical trials. reduce the risk of age-related diseases and • Many uncertainties remain about the effects conditions. that treatments for ageing would have • Strong market demand is driving investment on human health span and lifespan, the in geroscience research, particularly in economy, models of care, health inequalities, the US. Investment in this area has been personal identity, and how people work and highlighted as a key opportunity for the UK in live later in life. the future. • There are calls for an ethical framework • Animal research has led to the discovery for geroscience research to help guide of several potential interventions for ageing researchers, policy makers and consumers. INTRODUCTION In most countries, people are living longer and number of older people is predicted to increase healthier lives than ever, but are still spending markedly over the next 25 years,2 addressing a significant number of years in poor health age-related health conditions is a pressing towards the end of their lives.1 Common societal challenge. Healthy ageing is a priority conditions experienced by older people include policy area for the World Health Organization and cardiovascular disease, cancer, dementia, governments around the globe. arthritis, and general frailty. Given that the Geroscience, also called biogerontology, is a we are healthy – than tackling each condition field of research that is exploring the biological individually. This briefing note summarises processes that underlie ageing. Researchers the main scientific developments to date, and working in this field believe that intervening in the potential ethical and social issues that the these processes could be a more efficient way discovery of a treatment for ageing might raise. of increasing health span – the number of years BIOLOGICAL AGEING Biological ageing is a progressive decline in Hundreds of genes also have been found to bodily function and an increasing susceptibility be involved in ageing.4 Recent advances in the to disease and death as we get older. There tools of research, such as genome sequencing, is no consensus about the precise processes computer modelling, data science, and the that cause biological ageing, although it is clear collection of long-term data from specific that no single mechanism is responsible. Cell groups of people, are likely to accelerate our damage and errors in DNA accumulate over our understanding of ageing processes in the near lives, eventually leading to cellular dysfunction.3 future.5 INVESTMENT IN AGEING RESEARCH Large amounts of public and private funding lead longer and healthier lives”.6 Anti-ageing are being directed towards research on biotech has been described as: “risky and most ageing, driven by strong market demand. likely to fail, but if one company is successful the The US is the world leader in geroscience, outcomes would be monumental”.7 Geroscience with several government-funded research research groups and companies also exist in programmes on ageing, such as the US almost every other developed country in the National Institute on Aging, and a number of world, with particularly active centres in Germany, biotechnology companies exploring potential Spain, Australia, and the UK. However, a recent ageing interventions, many backed by wealthy Government strategy for the life sciences entrepreneurs. Google founders Sergey Brin suggests that the UK has been underperforming and Larry Page, for example, have launched in the field of ageing research, and investment in biotechnology company Calico, which is seeking this field is highlighted as a key opportunity for to “devise interventions that enable people to the UK in the future.8 POTENTIAL AGEING TREATMENTS Although questions remain about the underlying responsiveness of this enzyme has been found causes of ageing, animal studies have shown that to decline with ageing, suggesting that metformin it is possible to intervene in ageing processes. may have beneficial effects on the ageing The main scientific developments in the search process.10 The Targeting Aging with Metformin for ageing interventions are summarised below.9 (TAME) clinical trial in the US, expected to start in 2018, will explore the effects of metformin on METFORMIN ageing in 3,000 men and women aged 60 or over who have no existing serious illnesses.11 This Metformin has been used as an effective is the first trial to study the effects of a drug on diabetes drug for over 50 years. It works partly biological ageing, which could pave the way by enhancing the activity of an enzyme involved to ageing being recognised by regulators as a in metabolic processes essential for health. The disease and to further drug trials in this area. Nuffield Council on Bioethics 2 HORMESIS, DIETARY RESTRICTION AND age, and injecting stem cells into animals has RAPAMYCIN been shown to enhance the repair of age-related damage in organs such as the brain, and increase Inducing a mild stress response in cells, known lifespan.23 Until recently, there were significant as hormesis, can delay ageing in animals. barriers to the use of stem cells for therapeutic Exercise, heat, and radiation are all hormesis- purposes in humans. Stem cells can be derived inducing agents.12 However, the best studied from donated embryos, but are prone to immune agent is dietary restriction without malnutrition, rejection when transplanted. The use of embryos which can extend healthy lifespan in a range of is also ethically controversial. In 2006, it was animals. In humans, it has been shown to reduce discovered that stem cells could be generated risk factors for diabetes, cardiovascular disease, from adult cells, opening up a range of new and cancer, and to slow biological ageing, but possibilities in the field of regenerative medicine. dietary restriction is not desirable or realistic for The effects of stem cell therapy on age-related most people.13 Similar effects are seen when conditions such as frailty and Alzheimer’s disease the activity of metabolic pathways that detect are being explored in early-stage clinical trials nutrients are reduced by gene mutations or in the US.24 Unproven and unlicensed stem cell drugs.14 Rapamycin, for example, a drug used treatments for a range of ‘rejuvenation’ purposes to prevent organ transplant rejection, inhibits are also being offered by private clinics across the pathway involved in nutrient sensitivity and the world.25 extends lifespan in animals.15 Despite the risk of serious side-effects, the effects of rapamycin YOUNG BLOOD on frailty in people aged 60 and over with heart disease are being explored in a small clinical Research suggests that blood from young mice trial in the US.16 A similar drug, RAD001, has can have a rejuvenating effect in older mice. been shown in a small trial to boost the immune It was recently found that injecting one blood system of healthy people aged 65 years or over.17 protein in particular called GDF11 can regenerate animal organs including the heart and brain.26 RESVERATROL AND OTHER SIRTUIN This was hailed as a major breakthrough in INHIBITORS ageing research,27 but the findings have been disputed by companies developing drugs A group of enzymes called sirtuins have a role that inhibit, rather than stimulate, GDF11.28 in many cellular processes that affect ageing.18 Nevertheless, a number of commercial clinical Chemicals that interact with sirtuins have strong trials are exploring the effects of transfusions potential as ageing treatments. Resveratrol, for of young blood in humans. One US study is example, a naturally occurring chemical found in recruiting 600 people aged 35 and older who red wine, is known to affect sirtuin activity and will pay to receive a blood transfusion from a the ageing process in animals.19 The resveratrol donor aged 25 or younger.29 Critics suggest the anti-ageing supplement market is already big design of the study is dubious, both ethically and business globally, but only small amounts of scientifically.30 Another trial, also in the US, is resveratrol are absorbed into the body when studying the effects of young blood transfusion administered in humans and the long-term health in a small number of people with Alzheimer’s effects are unproven.20 Synthetically produced disease.31 sirtuin inhibitors show more promise, and some have been found to improve the health and TELOMERASE AND TA-65 extend the lifespan of mice.21 The pharmaceutical industry has invested heavily in the development The discovery in the 1980s that telomeres, of synthetic sirtuin inhibitors, but they have not the tips of chromosomes, are vital for cell yet been translated into drugs for human use.22 division and repair earned the researchers a Nobel prize.32 Telomere shortening occurs with STEM CELL THERAPY ageing and is associated with an increased incidence of disease and death.33 The enzyme Stem cells are unspecialised cells involved in telomerase lengthens telomeres and thus has repairing and replenishing other cells and tissues been suggested as a target for anti-ageing in the body. Stem cell function decreases with interventions. The plant-based supplement Bioethics briefing note: The search for a treatment for ageing 3 TA-65, said to increase telomerase activity, is working on developing drugs, collectively called available to buy worldwide as an anti-ageing aid. senolytics, that will selectively kill senescent cells. Industry studies suggest TA-65 has beneficial Several senolytics have been found to work in effects on the health span of mice and humans.34 mice and it is likely they will be tested in human The US-based manufacturer is now conducting trials in the near future.40,41 clinical trials on healthy adults.35 However, the reliability and independence of these studies HORMONES AND ANTIOXIDANTS have been questioned and there are concerns that stimulating telomerase activity could The anti-ageing effects of hormones have been increase the risk of cancer.36 Another way of studied for many years.
Load more

Recommended publications
  • Biogerontology: a Novel Tool to Stay Healthy in Old Age
    MoPAct Policy Brief: 5 Biogerontology: a novel tool to stay healthy in old age Policy priority Healthy lifestyle interventions in particular regarding nutrition and vaccination need to be implemented early in life with a lifecourse perspective. Summary: Key findings: • Accumulating evidence from experimental studies shows that aging is not inevitably linked with the development of chronic diseases. • Only 20-25% of healthy life expectancy (HLE) is predetermined by genes; lifestyle and environment play a major role. • Age-associated accumulation of molecular and cellular damage can be prevented or greatly delayed by lifestyle interventions e.g. dietary manipulations. • Classical strategies (e.g. nutrition, exercise, vaccination) require broad communication to public. • Novel strategies (e.g. dietary interventions, novel drugs, stem cells) need successful translation from the understanding of molecular mechanism to animal models to clinic. • To be successful interventions need to be started early Figure 1. Strategies to increase HLE. (1) Classical interventions include nutrition, exercise, vaccination, no smoking/alcohol/drugs. (2) Novel interventions include in life with a life-course perspective. dietary interventions, clearance of senescent and damaged cells, mitohormetics, stem cells, drugs against inflammation, rejuvenation factors from blood, telomeres, Background: epigenetic drugs, chaperons and proteolytic systems (novel interventions adapted from López-Otín et al., Cell 2013). Population aging is progressing fast in all developed countries. Aging is associated with the development of multiple serious chronic illnesses, including type 2 diabetes, hypertension, heart Prevention disease, stroke, cancer, cognitive impairment and increased Prevention prior to the development of age-associated diseases morbidity and mortality from infectious diseases. As people is key for successful aging.
    [Show full text]
  • Mixing Old and Young: Enhancing Rejuvenation and Accelerating Aging
    Mixing old and young: enhancing rejuvenation and accelerating aging Ashley Lau, … , James L. Kirkland, Stefan G. Tullius J Clin Invest. 2019;129(1):4-11. https://doi.org/10.1172/JCI123946. Review Donor age and recipient age are factors that influence transplantation outcomes. Aside from age-associated differences in intrinsic graft function and alloimmune responses, the ability of young and old cells to exert either rejuvenating or aging effects extrinsically may also apply to the transplantation of hematopoietic stem cells or solid organ transplants. While the potential for rejuvenation mediated by the transfer of youthful cells is currently being explored for therapeutic applications, aspects that relate to accelerating aging are no less clinically significant. Those effects may be particularly relevant in transplantation with an age discrepancy between donor and recipient. Here, we review recent advances in understanding the mechanisms by which young and old cells modify their environments to promote rejuvenation- or aging-associated phenotypes. We discuss their relevance to clinical transplantation and highlight potential opportunities for therapeutic intervention. Find the latest version: https://jci.me/123946/pdf REVIEW The Journal of Clinical Investigation Mixing old and young: enhancing rejuvenation and accelerating aging Ashley Lau,1 Brian K. Kennedy,2,3,4,5 James L. Kirkland,6 and Stefan G. Tullius1 1Division of Transplant Surgery, Department of Surgery, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts, USA. 2Departments of Biochemistry and Physiology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore. 3Singapore Institute for Clinical Sciences, Singapore. 4Agency for Science, Technology and Research (A*STAR), Singapore.
    [Show full text]
  • SENS-Research-Foundation-2019
    by the year 2050, cardiovascular an estimated 25-30 the american 85 percent of adults disease years and older age 85 or older remains the most population will suffer from common cause of 2 1 2 dementia. death in older adults. triple. THE CLOCK IS TICKING. By 2030, annual direct The estimated cost of medical costs associated dementia worldwide was 62% of Americans with cardiovascular $818 billion diseases in the united over age 65 have in 2015 and is states are expected to more than one expected to grow to rise to more than chronic condition.1 3 $2 trillion $818 billion. by 2030.1 References: (1) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5732407/, (2) https://www.who.int/ageing/publications/global_health.pdf, (3) https://www.cdcfoundation.org/pr/2015/heart-disease-and-stroke-cost-america-nearly-1-billion-day-medical-costs-lost-productivity sens research foundation board of directors Barbara Logan Kevin Perrott Bill Liao Chairperson Treasurer Secretary Michael Boocher Kevin Dewalt James O’Neill Jonathan Cain Michael Kope Frank Schuler 02 CONTENTS 2019 Annual Report 04 Letter From The CEO 06 Outreach & Fundraising 08 Finances 09 Donors erin ashford photography 14 Education 26 Investments 20 Conferences & Events 30 Research Advisory Board 23 Speaking Engagements 31 10 Years Of Research 24 Alliance 32 MitoSENS 34 LysoSENS 35 Extramural Research 38 Publications 39 Ways to Donate cover Photo (c) Mikhail Leonov - stock.adobe.com special 10th anniversary edition 03 FROM THE CEO It’s early 2009, and it’s very late at night. Aubrey, Jeff, Sarah, Kevin, and Mike are sitting around a large table covered in papers and half-empty food containers.
    [Show full text]
  • Forkhead Transcription Factors and Ageing
    Oncogene (2008) 27, 2351–2363 & 2008 Nature Publishing Group All rights reserved 0950-9232/08 $30.00 www.nature.com/onc REVIEW Forkhead transcription factors and ageing L Partridge1 and JC Bru¨ ning2 1Institute of Healthy Ageing, GEE, London, UK; 2Department of Mouse Genetics and Metabolism, Institute for Genetics University of Cologne, Cologne, Germany Mutations in single genes and environmental interventions Forkhead transcription factors are turning out to play can extend healthy lifespan in laboratory model organi- a key role in invertebrate models ofextension ofhealthy sms. Some of the mechanisms involved show evolutionary lifespan by single-gene mutations, and evidence is conservation, opening the way to using simpler inverte- mounting for their importance in mammals. Forkheads brates to understand human ageing. Forkhead transcrip- can also play a role in extension oflifespanby dietary tion factors have been found to play a key role in lifespan restriction, an environmental intervention that also extension by alterations in the insulin/IGF pathway and extends lifespan in diverse organisms (Kennedy et al., by dietary restriction. Interventions that extend lifespan 2007). Here, we discuss these findings and their have also been found to delay or ameliorate the impact of implications. The forkhead family of transcription ageing-related pathology and disease, including cancer. factors is characterized by a type of DNA-binding Understanding the mode of action of forkheads in this domain known as the forkhead box (FOX) (Weigel and context will illuminate the mechanisms by which ageing Jackle, 1990). They are also called winged helix acts as a risk factor for ageing-related disease, and could transcription factors because of the crystal structure lead to the development of a broad-spectrum, preventative ofthe FOX, ofwhich the forkheadscontain a medicine for the diseases of ageing.
    [Show full text]
  • World Population Ageing 2019
    World Population Ageing 2019 Highlights ST/ESA/SER.A/430 Department of Economic and Social Affairs Population Division World Population Ageing 2019 Highlights United Nations New York, 2019 The Department of Economic and Social Affairs of the United Nations Secretariat is a vital interface between global policies in the economic, social and environmental spheres and national action. The Department works in three main interlinked areas: (i) it compiles, generates and analyses a wide range of economic, social and environmental data and information on which States Members of the United Nations draw to review common problems and take stock of policy options; (ii) it facilitates the negotiations of Member States in many intergovernmental bodies on joint courses of action to address ongoing or emerging global challenges; and (iii) it advises interested Governments on the ways and means of translating policy frameworks developed in United Nations conferences and summits into programmes at the country level and, through technical assistance, helps build national capacities. The Population Division of the Department of Economic and Social Affairs provides the international community with timely and accessible population data and analysis of population trends and development outcomes for all countries and areas of the world. To this end, the Division undertakes regular studies of population size and characteristics and of all three components of population change (fertility, mortality and migration). Founded in 1946, the Population Division provides substantive support on population and development issues to the United Nations General Assembly, the Economic and Social Council and the Commission on Population and Development. It also leads or participates in various interagency coordination mechanisms of the United Nations system.
    [Show full text]
  • Shared Ageing Research Models (Sharm): a New Facility to Support Ageing Research
    Biogerontology (2013) 14:789–794 DOI 10.1007/s10522-013-9457-0 METHOD Shared Ageing Research Models (ShARM): a new facility to support ageing research Adele L. Duran • Paul Potter • Sara Wells • Tom Kirkwood • Thomas von Zglinicki • Anne McArdle • Cheryl Scudamore • Qing-Jun Meng • Gerald de Haan • Anne Corcoran • Ilaria Bellantuono Received: 5 July 2013 / Accepted: 16 August 2013 / Published online: 2 October 2013 Ó The Author(s) 2013. This article is published with open access at Springerlink.com Abstract In order to manage the rise in life expec- Wellcome Trust, open to all investigators. It collects, tancy and the concomitant increased occurrence of stores and distributes flash frozen tissues from aged age-related diseases, research into ageing has become murine models through its biorepository and provides a strategic priority. Mouse models are commonly a database of live ageing mouse colonies available in utilised as they share high homology with humans and the UK and abroad. It also has an online environment show many similar signs and diseases of ageing. (MICEspace) for collation and analysis of data from However, the time and cost needed to rear aged communal models and discussion boards on subjects cohorts can limit research opportunities. Sharing of such as the welfare of ageing animals and common resources can provide an ethically and economically endpoints for intervention studies. Since launching in superior framework to overcome some of these issues July 2012, thanks to the generosity of researchers in but requires dedicated infrastructure. Shared Ageing UK and Europe, ShARM has collected more than Research Models (ShARM) (www.ShARMUK.org) 2,500 tissues and has in excess of 2,000 mice regis- is a new, not-for-profit organisation funded by tered in live ageing colonies.
    [Show full text]
  • Viewer Comments
    Article Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis Graphical abstract Authors Christopher D. Wiley, Rishi Sharma, Sonnet S. Davis, ..., Marco Demaria, Arvind Ramanathan, Judith Campisi Correspondence [email protected] (C.D.W.), [email protected] (A.R.), [email protected] (J.C.) In brief Senolytics, transgenic, and pharmacological interventions that selectively kill senescent cells are currently in clinical trials aiming to treat age-related degenerative pathologies. Here, Wiley et al. discover that senescent cells produce multiple signaling lipids known as oxylipins. One oxylipin, dihomo-15d-PGJ2, promotes features of senescence by activating RAS and is released from cells during senolysis, serving as the first biomarker of the Highlights process in culture and in vivo. d Senescent cells make several oxylipins, dihomo- prostaglandins, and leukotrienes d Dihomo-15d-PGJ2 is intracellular during senescence and released during senolysis d Dihomo-15d-PGJ2 activates RAS, promoting senescence and the SASP d Positive feedback between prostaglandins, RAS, and p53 maintains senescence Wiley et al., 2021, Cell Metabolism 33, 1–13 June 1, 2021 ª 2021 Published by Elsevier Inc. https://doi.org/10.1016/j.cmet.2021.03.008 ll Please cite this article in press as: Wiley et al., Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis, Cell Metabolism (2021), https://doi.org/10.1016/j.cmet.2021.03.008 ll Article Oxylipin biosynthesis reinforces cellular senescence and allows detection of senolysis Christopher D. Wiley,1,2,* Rishi Sharma,1 Sonnet S. Davis,1 Jose Alberto Lopez-Dominguez,1 Kylie P. Mitchell,1 Samantha Wiley,1 Fatouma Alimirah,1 Dong Eun Kim,1 Therese Payne,1 Andrew Rosko,1 Eliezer Aimontche,1 Sharvari M.
    [Show full text]
  • Read Our New Annual Report
    The seeds of a concept. The roots of an idea. The potential of a world free of age-related disease. Photo: Sherry Loeser Photography SENS Research Foundation Board of Directors Barbara Logan, Chair Bill Liao, Secretary Kevin Perrott, Treasurer Michael Boocher Jonathan Cain Kevin Dewalt Michael Kope Jim O’Neill Frank Schüler Sherry Loeser Photography 2 Contents CEO Letter (Jim O’Neill) 4 Finances 5 Donors 6 - 7 Fundraising & Conferences 8 - 9 Around the World with Aubrey de Grey 10 Outreach 11 Founding CEO Tribute & Underdog Pharmaceuticals 12 - 13 Investments 14 Welcome New Team Members 15 Education 16 - 17 Publications & Research Advisory Board 18 Research Summaries 19 - 22 Ways to Donate 23 The SRF Team Front row: Anne Corwin (Engineer/Editor), Amutha Boominathan (MitoSENS Group Lead), Alexandra Stolzing (VP of Research), Aubrey de Grey (Chief Science Officer), Jim O’Neill (CEO), Bhavna Dixit (Research Associate). Center row: Caitlin Lewis (Research Associate), Lisa Fabiny-Kiser (VP of Operations), Gary Abramson (Graphics), Maria Entraigues-Abramson (Global Outreach Coordinator), Jessica Lubke (Administrative Assistant). Back row: Tesfahun Dessale Admasu (Research Fellow), Amit Sharma (ImmunoSENS Group Lead), Michael Rae (Science Writer), Kelly Protzman (Executive Assistant). Not Pictured: Greg Chin (Director, SRF Education), Ben Zealley (Website/Research Assistant/ Deputy Editor) Photo: Sherry Loeser Photography, 2019 3 From the CEO At our 2013 conference at Queens College, Cambridge, I closed my talk by saying, “We should not rest until we make aging an absurdity.” We are now in a very different place. After a lot of patient explanation, publication of scientific results, conferences, and time, our community persuaded enough scientists of the feasibility of the damage repair approach to move SENS and SENS Research Foundation from the fringes of scientific respectability to the vanguard of a mainstream community of scientists developing medical therapies to tackle human aging.
    [Show full text]
  • Age-Dependent Deterioration of Nuclear Pore Assembly in Mitotic
    RESEARCH ARTICLE Age-dependent deterioration of nuclear pore assembly in mitotic cells decreases transport dynamics Irina L Rempel1, Matthew M Crane2, David J Thaller3, Ankur Mishra4, Daniel PM Jansen1, Georges Janssens1, Petra Popken1, Arman Aks¸it1, Matt Kaeberlein2, Erik van der Giessen4, Anton Steen1, Patrick R Onck4, C Patrick Lusk3, Liesbeth M Veenhoff1* 1European Research Institute for the Biology of Ageing (ERIBA), University of Groningen, University Medical Center Groningen, Groningen, Netherlands; 2Department of Pathology, University of Washington, Seattle, United States; 3Department of Cell Biology, Yale School of Medicine, New Haven, United States; 4Zernike Institute for Advanced Materials, University of Groningen, Groningen, Netherlands Abstract Nuclear transport is facilitated by the Nuclear Pore Complex (NPC) and is essential for life in eukaryotes. The NPC is a long-lived and exceptionally large structure. We asked whether NPC quality control is compromised in aging mitotic cells. Our images of single yeast cells during aging, show that the abundance of several NPC components and NPC assembly factors decreases. Additionally, the single-cell life histories reveal that cells that better maintain those components are longer lived. The presence of herniations at the nuclear envelope of aged cells suggests that misassembled NPCs are accumulated in aged cells. Aged cells show decreased dynamics of transcription factor shuttling and increased nuclear compartmentalization. These functional changes are likely caused by the presence
    [Show full text]
  • Longevity, Aging, and Caloric Restriction : Clive Maine Mccay and the Construction of a Multidisciplinary Research Program
    This document is downloaded from DR‑NTU (https://dr.ntu.edu.sg) Nanyang Technological University, Singapore. Longevity, aging, and caloric restriction : Clive Maine McCay and the construction of a multidisciplinary research program Park, Hyung Wook 2010 Park, H. W. (2010). Longevity, Aging, and Caloric Restriction: Clive Maine McCay and the Construction of a Multidisciplinary Research Program. Historical Studies in the Natural Sciences, 40(1), 79‑124. https://hdl.handle.net/10356/96440 https://doi.org/10.1525/hsns.2010.40.1.79 © 2010 by the Regents of the University of California. This paper was published in Historical Studies in the Natural Sciences and is made available as an electronic reprint (preprint) with permission of the Regents of the University of California. The paper can be found at the following official DOI: [http://dx.doi.org/10.1525/hsns.2010.40.1.79]. One print or electronic copy may be made for personal use only. Systematic or multiple reproduction, distribution to multiple locations via electronic or other means, duplication of any material in this paper for a fee or for commercial purposes, or modification of the content of the paper is prohibited and is subject to penalties under law. Downloaded on 02 Oct 2021 12:53:04 SGT HYUNG WOOK PARK* Longevity, Aging, and Caloric Restriction: Clive Maine McCay and the Construction of a Multidisciplinary Research Program ABSTRACT Since the 1930s scientists from fields such as biochemistry, pathology, immunology, genetics, neuroscience, and nutrition have studied the relation of dietary caloric intake to longevity and aging. This paper discusses how Clive Maine McCay, a professor of animal husbandry at Cornell University, began his investigation of the topic and pro- moted it as a productive research program in the multidisciplinary science of geron- tology.
    [Show full text]
  • HCB 524 — Transhumanism
    HCB 524 Special Topic in Bioethics Fall Semester, 2019. Tuesdays 6-8:30pm. Instructor of Record: Adam Sepe, MA, MLS(ASCP)cm [email protected] Course Description: Transhumanism and [Human?] Dignity. Throughout human history — and prehistory for that matter — technological advancement has drastically altered every aspect of human life. Most of us will say that many advents — such as cooking and the wheel — have been largely, if not entirely, beneficial. Would we say the same of all technology? Surely each of us can list technologies that have, in the very least, some considerable downsides. So while history and experience can tell us that some technologies are beneficial and that some other technologies are harmful, how can we know what kind of impact future technology will have? For now we can’t, and so all we can do is try, to the best of our ability, to imagine such futures and develop our technology with these considerations in mind. ‘Transhumanism’ refers a diverse collection of ideas that have one at least thing in common: through future technology, humanity will be fundamentally altered to an unprecedented degree. Some even believe there will come a time when, through our own action, the word ‘human’ will be obsolete; that we will be succeeded by entities (or an entity) for which ‘human’ does not apply. Most people who identify as transhumanists are, to varying degrees, proponents of such technology. They are in favor of such alterations and they argue that these will be beneficial. In this course, we will take a critical look at transhumanist claims.
    [Show full text]
  • Dissecting Aging and Senescence—Current Concepts and Open Lessons
    cells Review Dissecting Aging and Senescence—Current Concepts and Open Lessons 1,2, , 1,2, 1 1,2 Christian Schmeer * y , Alexandra Kretz y, Diane Wengerodt , Milan Stojiljkovic and Otto W. Witte 1,2 1 Hans-Berger Department of Neurology, Jena University Hospital, 07747 Jena, Thuringia, Germany; [email protected] (A.K.); [email protected] (D.W.); [email protected] (M.S.); [email protected] (O.W.W.) 2 Jena Center for Healthy Ageing, Jena University Hospital, 07747 Jena, Thuringia, Germany * Correspondence: [email protected] These authors have contributed equally. y Received: 2 October 2019; Accepted: 13 November 2019; Published: 15 November 2019 Abstract: In contrast to the programmed nature of development, it is still a matter of debate whether aging is an adaptive and regulated process, or merely a consequence arising from a stochastic accumulation of harmful events that culminate in a global state of reduced fitness, risk for disease acquisition, and death. Similarly unanswered are the questions of whether aging is reversible and can be turned into rejuvenation as well as how aging is distinguishable from and influenced by cellular senescence. With the discovery of beneficial aspects of cellular senescence and evidence of senescence being not limited to replicative cellular states, a redefinition of our comprehension of aging and senescence appears scientifically overdue. Here, we provide a factor-based comparison of current knowledge on aging and senescence, which we converge on four suggested concepts, thereby implementing the newly emerging cellular and molecular aspects of geroconversion and amitosenescence, and the signatures of a genetic state termed genosenium.
    [Show full text]